SARS-COV-2 VACCINES AND NEURODEGENERATIVE DISEASE

Since December 2020, when several novel unprecedented vaccines against SARS-CoV-2 began to be approved for emergency use, there has been a worldwide effort to get these vaccines into the arms of as many people as possible as fast as possible. These vaccines have been developed “at warp speed,” given the urgency of the situation with the COVID-19 pandemic. Most governments have embraced the notion that these vaccines are the only path towards resolution of this pandemic, which is crippling the economies of many countries.

-

(Article)

Recent Posts

See All

The Centers for Disease Control and Prevention (CDC) revised its COVID-19 guidance on Aug. 11, stating that the United States should move away from quarantines and social distancing and focus on treat